Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim U Krohne

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Die Ophthalmologie|June 17, 2024
[Vitreomacular Interface Diseases : Epiretinal membrane, Macular Hole and Co.]Lars-Olof Hattenbach, Tim U Krohne
International Journal of Molecular Sciences|November 14, 2020
The Rise of Retinal Organoids for Vision ResearchKritika Sharma, Tim U Krohne, Volker Busskamp
Klinische Monatsblatter Fur Augenheilkunde|August 29, 2023
[Bilateral Scotomata in COVID-19]Leonie Menghesha, Rafael S Grajewski, Tim U Krohne
The Journal of Biological Chemistry|November 14, 2015
Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative DamageCarolina Brandstetter, Frank G Holz, Tim U Krohne
Investigative Ophthalmology & Visual Science|August 22, 2009
Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cellsTim U Krohne, Frank G Holz, Jürgen Kopitz
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 27, 2006
New pharmacologic approaches to therapy for age-related macular degenerationNicole Eter, Tim U Krohne, Frank G Holz
Die Ophthalmologie|November 28, 2025
[Sulphur hexafluoride (SF<sub>6</sub>) and climate impact: is the medical use still justified?]Tim U Krohne, Johannes Birtel, Peter Charbel Issa
Retina (Philadelphia, Pa.)|July 9, 2011
Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humansCarsten H Meyer, Tim U Krohne, Frank G Holz
Acta Ophthalmologica|February 19, 2010
Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humansCarsten H Meyer, Tim U Krohne, Frank G Holz
BMC Ophthalmology|January 4, 2024
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathyVasilena Sitnilska, Petra Schiller, Tim U Krohne, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Die Ophthalmologie|June 17, 2024
[Vitreomacular Interface Diseases : Epiretinal membrane, Macular Hole and Co.]Lars-Olof Hattenbach, Tim U Krohne
International Journal of Molecular Sciences|November 14, 2020
The Rise of Retinal Organoids for Vision ResearchKritika Sharma, Tim U Krohne, Volker Busskamp
Klinische Monatsblatter Fur Augenheilkunde|August 29, 2023
[Bilateral Scotomata in COVID-19]Leonie Menghesha, Rafael S Grajewski, Tim U Krohne
The Journal of Biological Chemistry|November 14, 2015
Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative DamageCarolina Brandstetter, Frank G Holz, Tim U Krohne
Investigative Ophthalmology & Visual Science|August 22, 2009
Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cellsTim U Krohne, Frank G Holz, Jürgen Kopitz
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 27, 2006
New pharmacologic approaches to therapy for age-related macular degenerationNicole Eter, Tim U Krohne, Frank G Holz
Die Ophthalmologie|November 28, 2025
[Sulphur hexafluoride (SF<sub>6</sub>) and climate impact: is the medical use still justified?]Tim U Krohne, Johannes Birtel, Peter Charbel Issa
Retina (Philadelphia, Pa.)|July 9, 2011
Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humansCarsten H Meyer, Tim U Krohne, Frank G Holz
Acta Ophthalmologica|February 19, 2010
Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humansCarsten H Meyer, Tim U Krohne, Frank G Holz
BMC Ophthalmology|January 4, 2024
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathyVasilena Sitnilska, Petra Schiller, Tim U Krohne, et al.
Pageof 9